These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32359039)

  • 41. New insights on biomarkers in systemic vasculitis.
    Perez-Alamino R; Maldonado-Ficco H
    Curr Rheumatol Rep; 2015 Mar; 17(3):12. PubMed ID: 25740705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update in paediatric vasculitis.
    Ozen S; Fuhlbrigge RC
    Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):679-88. PubMed ID: 19853832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular Disease in the Systemic Vasculitides.
    Soulaidopoulos S; Madenidou AV; Daoussis D; Melissaropoulos K; Mavrogeni S; Kitas G; Dimitroulas T
    Curr Vasc Pharmacol; 2020; 18(5):463-472. PubMed ID: 32000652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Systemic vasculitides classification].
    Guillevin L; Terrier B
    Presse Med; 2012 Oct; 41(10):986-95. PubMed ID: 22884126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurologic presentations of systemic vasculitides.
    Minagar A; Fowler M; Harris MK; Jaffe SL
    Neurol Clin; 2010 Feb; 28(1):171-84. PubMed ID: 19932380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary complications of systemic vasculitides.
    O'Sullivan BP
    Paediatr Respir Rev; 2012 Mar; 13(1):37-43. PubMed ID: 22208792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Audiovestibular manifestations in systemic vasculitis].
    Amor Dorado JC; Barreira Fernández Mdel P; Regueiro Villarin S; González-Gay MA
    Acta Otorrinolaringol Esp; 2009; 60(6):432-42. PubMed ID: 19909720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group Registry.
    Iudici M; Puéchal X; Pagnoux C; Quartier P; Agard C; Aouba A; Büchler M; Cevallos R; Cohen P; de Moreuil C; Guilpain P; Le Quellec A; Roblot P; Serratrice J; Bachmeyer C; Daugas É; Terrier B; Mouthon L; Guillevin L;
    Arthritis Rheumatol; 2015 Jul; 67(7):1959-65. PubMed ID: 25808634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Skin diseases due to systemic vasculitides and vasculopathies].
    Volc S; Maier JC; Röcken M
    Hautarzt; 2016 Dec; 67(12):948-959. PubMed ID: 27864582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large vessel vasculitides: update for the cardiologist.
    Luqmani R
    Curr Opin Cardiol; 2012 Nov; 27(6):578-84. PubMed ID: 23032715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroophthalmologic Aspects of the Vasculitides.
    Younger DS
    Neurol Clin; 2019 May; 37(2):383-397. PubMed ID: 30952415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cutaneous alterations in vasculitides : Part 2: Special aspects of diseases of large, medium and small vessels].
    Sunderkötter C; Michl C
    Internist (Berl); 2019 Aug; 60(8):805-813. PubMed ID: 31300830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic vasculitis.
    Sharma P; Sharma S; Baltaro R; Hurley J
    Am Fam Physician; 2011 Mar; 83(5):556-65. PubMed ID: 21391523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small-Medium Vessel Vasculitides: is the Complement System a Potential Forgotten Target?
    Ballanti E; Chimenti MS; Perricone R
    Isr Med Assoc J; 2015 Feb; 17(2):85-92. PubMed ID: 26223083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One year in review 2018: systemic vasculitis.
    Elefante E; Bond M; Monti S; Lepri G; Cavallaro E; Felicetti M; Calabresi E; Posarelli C; Talarico R; Quartuccio L; Baldini C
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):12-32. PubMed ID: 29799395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fulminant systemic vasculitis in systemic lupus erythematosus. Case report and review of the literature.
    Medina G; González-Pérez D; Vázquez-Juárez C; Sánchez-Uribe M; Saavedra MA; Jara LJ
    Lupus; 2014 Nov; 23(13):1426-9. PubMed ID: 25107938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results.
    Mahr A; Chaigne-Delalande S; De Menthon M
    Curr Opin Rheumatol; 2012 May; 24(3):261-6. PubMed ID: 22456283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trials on systemic necrotizing vasculitides.
    Guillevin L
    Presse Med; 2010 Jun; 39(6):653-9. PubMed ID: 20206461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasculitides with cutaneous expression in children: clinico-pathological correlations.
    Borroni G; Grassi S; Carugno A
    G Ital Dermatol Venereol; 2015 Feb; 150(1):51-71. PubMed ID: 25516220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The long-term outcomes of systemic vasculitis.
    Westman K; Flossmann O; Gregorini G
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i60-6. PubMed ID: 25601266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.